{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:58:18Z","timestamp":1785862698856,"version":"3.56.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10928-017-9557-6","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T16:42:39Z","timestamp":1511455359000},"page":"215-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Modeling energy intake and body weight effects of a long-acting amylin analogue"],"prefix":"10.1007","volume":"45","author":[{"given":"Annika","family":"Brings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Markus","family":"Borghardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Skarbaliene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Baader-Pagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Deryabina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Rist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4417-098X","authenticated-orcid":false,"given":"Stefan","family":"Scheuerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,23]]},"reference":[{"issue":"1","key":"9557_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pharmthera.2007.09.001","volume":"117","author":"JD Fernstrom","year":"2008","unstructured":"Fernstrom JD, Choi S (2008) The development of tolerance to drugs that suppress food intake. Pharmacol Ther 117(1):105\u2013122. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.09.001","journal-title":"Pharmacol Ther"},{"issue":"7","key":"9557_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/jama.295.7.761","volume":"295","author":"FX Pi-Sunyer","year":"2006","unstructured":"Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295(7):761\u2013775. https:\/\/doi.org\/10.1001\/jama.295.7.761","journal-title":"JAMA"},{"issue":"3","key":"9557_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/j.1550-8528.1996.tb00544.x","volume":"4","author":"GA Bray","year":"1996","unstructured":"Bray GA, Ryan DH, Gordon D, Heidingsfelder S, Cerise F, Wilson K (1996) A double-blind randomized placebo-controlled trial of sibutramine. Obes Res 4(3):263\u2013270","journal-title":"Obes Res"},{"issue":"9248","key":"9557_CR4","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","volume":"356","author":"WP James","year":"2000","unstructured":"James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WH, Van Gaal LF (2000) Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine trial of obesity reduction and maintenance. Lancet 356(9248):2119\u20132125","journal-title":"Lancet"},{"issue":"11","key":"9557_CR5","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.286.11.1331","volume":"286","author":"A Wirth","year":"2001","unstructured":"Wirth A, Krause J (2001) Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 286(11):1331\u20131339","journal-title":"JAMA"},{"issue":"5","key":"9557_CR6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/clpt.1992.68","volume":"51","author":"M Weintraub","year":"1992","unstructured":"Weintraub M (1992) Long-term weight control: The National Heart, Lung, and Blood Institute funded multimodal intervention study. Clin Pharmacol Ther 51(5):581\u2013585","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"9557_CR7","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/oby.2009.184","volume":"17","author":"E Ravussin","year":"2009","unstructured":"Ravussin E, Smith SR, Mitchell JA, Shringarpure R, Shan K, Maier H, Koda JE, Weyer C (2009) Enhanced weight loss with pramlintide\/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity (Silver Spring) 17(9):1736\u20131743. https:\/\/doi.org\/10.1038\/oby.2009.184","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"9557_CR8","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.2337\/dc08-0029","volume":"31","author":"SR Smith","year":"2008","unstructured":"Smith SR, Aronne LJ, Burns CM, Kesty NC, Halseth AE, Weyer C (2008) Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity. Diabetes Care 31(9):1816\u20131823. https:\/\/doi.org\/10.2337\/dc08-0029","journal-title":"Diabetes Care"},{"issue":"20","key":"9557_CR9","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.1073\/pnas.0706473105","volume":"105","author":"JD Roth","year":"2008","unstructured":"Roth JD, Roland BL, Cole RL, Trevaskis JL, Weyer C, Koda JE, Anderson CM, Parkes DG, Baron AD (2008) Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci USA 105(20):7257\u20137262. https:\/\/doi.org\/10.1073\/pnas.0706473105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"9557_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/sj.bjp.0706807","volume":"148","author":"A Fisas","year":"2006","unstructured":"Fisas A, Codony X, Romero G, Dordal A, Giraldo J, Merce R, Holenz J, Vrang N, Sorensen RV, Heal D, Buschmann H, Pauwels PJ (2006) Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats. Br J Pharmacol 148(7):973\u2013983. https:\/\/doi.org\/10.1038\/sj.bjp.0706807","journal-title":"Br J Pharmacol"},{"issue":"3","key":"9557_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1677\/JOE-10-0004","volume":"206","author":"AN Madsen","year":"2010","unstructured":"Madsen AN, Hansen G, Paulsen SJ, Lykkegaard K, Tang-Christensen M, Hansen HS, Levin BE, Larsen PJ, Knudsen LB, Fosgerau K, Vrang N (2010) Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome. J Endocrinol 206(3):287\u2013296. https:\/\/doi.org\/10.1677\/JOE-10-0004","journal-title":"J Endocrinol"},{"issue":"1\u20132","key":"9557_CR12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0006-8993(01)03330-3","volume":"928","author":"S Choi","year":"2002","unstructured":"Choi S, Jonak EM, Simpson L, Patil V, Fernstrom JD (2002) Intermittent, chronic fenfluramine administration to rats repeatedly suppresses food intake despite substantial brain serotonin reductions. Brain Res 928(1\u20132):30\u201339","journal-title":"Brain Res"},{"issue":"9","key":"9557_CR13","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1210\/en.2004-1663","volume":"146","author":"RJ Seeley","year":"2005","unstructured":"Seeley RJ, Burklow ML, Wilmer KA, Matthews CC, Reizes O, McOsker CC, Trokhan DP, Gross MC, Sheldon RJ (2005) The effect of the melanocortin agonist, MT-II, on the defended level of body adiposity. Endocrinology 146(9):3732\u20133738. https:\/\/doi.org\/10.1210\/en.2004-1663","journal-title":"Endocrinology"},{"issue":"10","key":"9557_CR14","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-2826.2002.00840.x","volume":"14","author":"A Sahu","year":"2002","unstructured":"Sahu A (2002) Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones. J Neuroendocrinol 14(10):796\u2013804","journal-title":"J Neuroendocrinol"},{"issue":"12","key":"9557_CR15","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1210\/en.2006-0393","volume":"147","author":"JD Roth","year":"2006","unstructured":"Roth JD, Hughes H, Kendall E, Baron AD, Anderson CM (2006) Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. Endocrinology 147(12):5855\u20135864. https:\/\/doi.org\/10.1210\/en.2006-0393","journal-title":"Endocrinology"},{"issue":"5","key":"9557_CR16","doi-asserted-by":"publisher","first-page":"R1855","DOI":"10.1152\/ajpregu.00297.2007","volume":"293","author":"C Mack","year":"2007","unstructured":"Mack C, Wilson J, Athanacio J, Reynolds J, Laugero K, Guss S, Vu C, Roth J, Parkes D (2007) Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. Am J Physiol Regul Integr Comp Physiol 293(5):R1855\u2013R1863. https:\/\/doi.org\/10.1152\/ajpregu.00297.2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"4","key":"9557_CR17","doi-asserted-by":"publisher","first-page":"E1112","DOI":"10.1152\/ajpendo.00395.2007","volume":"293","author":"JD Roth","year":"2007","unstructured":"Roth JD, Hughes H, Coffey T, Maier H, Trevaskis JL, Anderson CM (2007) Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats. Am J Physiol Endocrinol Metab 293(4):E1112\u2013E1117. https:\/\/doi.org\/10.1152\/ajpendo.00395.2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1\u20132","key":"9557_CR18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-8993(97)01057-3","volume":"779","author":"JC Donahey","year":"1998","unstructured":"Donahey JC, van Dijk G, Woods SC, Seeley RJ (1998) Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats. Brain Res 779(1\u20132):75\u201383","journal-title":"Brain Res"},{"issue":"11","key":"9557_CR19","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.2337\/diabetes.50.11.2530","volume":"50","author":"PJ Larsen","year":"2001","unstructured":"Larsen PJ, Fledelius C, Knudsen LB, Tang-Christensen M (2001) Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes 50(11):2530\u20132539","journal-title":"Diabetes"},{"issue":"7109","key":"9557_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nature05026","volume":"443","author":"GJ Morton","year":"2006","unstructured":"Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW (2006) Central nervous system control of food intake and body weight. Nature 443(7109):289\u2013295. https:\/\/doi.org\/10.1038\/nature05026","journal-title":"Nature"},{"key":"9557_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-3-642-24716-3_10","volume":"209","author":"TA Lutz","year":"2012","unstructured":"Lutz TA (2012) Effects of amylin on eating and adiposity. Handb Exp Pharmacol 209:231\u2013250. https:\/\/doi.org\/10.1007\/978-3-642-24716-3_10","journal-title":"Handb Exp Pharmacol"},{"issue":"12","key":"9557_CR22","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","volume":"69","author":"TA Lutz","year":"2012","unstructured":"Lutz TA (2012) Control of energy homeostasis by amylin. Cell Mol Life Sci 69(12):1947\u20131965. https:\/\/doi.org\/10.1007\/s00018-011-0905-1","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"9557_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1124\/pr.115.010629","volume":"67","author":"DL Hay","year":"2015","unstructured":"Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD (2015) Amylin: pharmacology, physiology, and clinical potential. Pharmacol Rev 67(3):564\u2013600. https:\/\/doi.org\/10.1124\/pr.115.010629","journal-title":"Pharmacol Rev"},{"issue":"12","key":"9557_CR24","doi-asserted-by":"publisher","first-page":"6054","DOI":"10.1210\/en.2007-0898","volume":"148","author":"JD Roth","year":"2007","unstructured":"Roth JD, Coffey T, Jodka CM, Maier H, Athanacio JR, Mack CM, Weyer C, Parkes DG (2007) Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity. Endocrinology 148(12):6054\u20136061. https:\/\/doi.org\/10.1210\/en.2007-0898","journal-title":"Endocrinology"},{"issue":"1","key":"9557_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000084488","volume":"5","author":"B Isaksson","year":"2005","unstructured":"Isaksson B, Wang F, Permert J, Olsson M, Fruin B, Herrington MK, Enochsson L, Erlanson-Albertsson C, Arnelo U (2005) Chronically administered islet amyloid polypeptide in rats serves as an adiposity inhibitor and regulates energy homeostasis. Pancreatology 5(1):29\u201336. https:\/\/doi.org\/10.1159\/000084488","journal-title":"Pancreatology"},{"issue":"9","key":"9557_CR26","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s11095-005-5882-3","volume":"22","author":"M Danhof","year":"2005","unstructured":"Danhof M, Alvan G, Dahl SG, Kuhlmann J, Paintaud G (2005) Mechanism-based pharmacokinetic-pharmacodynamic modeling-a new classification of biomarkers. Pharm Res 22(9):1432\u20131437. https:\/\/doi.org\/10.1007\/s11095-005-5882-3","journal-title":"Pharm Res"},{"issue":"3","key":"9557_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10928-011-9194-4","volume":"38","author":"J Fang","year":"2011","unstructured":"Fang J, DuBois DC, He Y, Almon RR, Jusko WJ (2011) Dynamic modeling of methylprednisolone effects on body weight and glucose regulation in rats. J Pharmacokinet Pharmacodyn 38(3):293\u2013316. https:\/\/doi.org\/10.1007\/s10928-011-9194-4","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"6","key":"9557_CR28","doi-asserted-by":"publisher","first-page":"e100073","DOI":"10.1371\/journal.pone.0100073","volume":"9","author":"M Jacquier","year":"2014","unstructured":"Jacquier M, Crauste F, Soulage CO, Soula HA (2014) A predictive model of the dynamics of body weight and food intake in rats submitted to caloric restrictions. PLoS One 9(6):e100073. https:\/\/doi.org\/10.1371\/journal.pone.0100073","journal-title":"PLoS One"},{"issue":"1","key":"9557_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cmet.2008.11.005","volume":"9","author":"J Tam","year":"2009","unstructured":"Tam J, Fukumura D, Jain RK (2009) A mathematical model of murine metabolic regulation by leptin: energy balance and defense of a stable body weight. Cell Metab 9(1):52\u201363. https:\/\/doi.org\/10.1016\/j.cmet.2008.11.005","journal-title":"Cell Metab"},{"issue":"1","key":"9557_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10928-014-9399-4","volume":"42","author":"P Gennemark","year":"2015","unstructured":"Gennemark P, Hjorth S, Gabrielsson J (2015) Modeling energy intake by adding homeostatic feedback and drug intervention. J Pharmacokinet Pharmacodyn 42(1):79\u201396. https:\/\/doi.org\/10.1007\/s10928-014-9399-4","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9557_CR31","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1038\/psp.2013.56","volume":"2","author":"K Ito","year":"2013","unstructured":"Ito K, Murphy D (2013) Application of ggplot2 to pharmacometric graphics. CPT 2:e79. https:\/\/doi.org\/10.1038\/psp.2013.56","journal-title":"CPT"},{"issue":"9","key":"9557_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1137\/0915088","volume":"33","author":"K Soetaert","year":"2010","unstructured":"Soetaert K, Petzoldt T, Setzer RW (2010) Solving differential equations in R: package deSolve. J Stat Softw 33(9):1\u201325. https:\/\/doi.org\/10.1137\/0915088","journal-title":"J Stat Softw"},{"issue":"6 Pt 2","key":"9557_CR33","first-page":"R1117","volume":"259","author":"FD Newby","year":"1990","unstructured":"Newby FD, DiGirolamo M, Cotsonis GA, Kutner MH (1990) Model of spontaneous obesity in aging male Wistar rats. Am J Physiol 259(6 Pt 2):R1117\u2013R1125","journal-title":"Am J Physiol"},{"issue":"1","key":"9557_CR34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/toxsci\/58.1.195","volume":"58","author":"MF Hubert","year":"2000","unstructured":"Hubert MF, Laroque P, Gillet JP, Keenan KP (2000) The effects of diet, ad Libitum feeding, and moderate and severe dietary restriction on body weight, survival, clinical pathology parameters, and cause of death in control Sprague-Dawley rats. Toxicol Sci 58(1):195\u2013207","journal-title":"Toxicol Sci"},{"issue":"3","key":"9557_CR35","doi-asserted-by":"publisher","first-page":"e1000045","DOI":"10.1371\/journal.pcbi.1000045","volume":"4","author":"CC Chow","year":"2008","unstructured":"Chow CC, Hall KD (2008) The dynamics of human body weight change. PLoS Comput Biol 4(3):e1000045. https:\/\/doi.org\/10.1371\/journal.pcbi.1000045","journal-title":"PLoS Comput Biol"},{"issue":"11","key":"9557_CR36","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1002\/oby.21653","volume":"24","author":"D Polidori","year":"2016","unstructured":"Polidori D, Sanghvi A, Seeley RJ, Hall KD (2016) How strongly does appetite counter weight loss? Quantification of the feedback control of human energy intake. Obesity (Silver Spring) 24(11):2289\u20132295. https:\/\/doi.org\/10.1002\/oby.21653","journal-title":"Obesity (Silver Spring)"},{"key":"9557_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.physbeh.2014.02.044","volume":"134","author":"CC Chow","year":"2014","unstructured":"Chow CC, Hall KD (2014) Short and long-term energy intake patterns and their implications for human body weight regulation. Physiol Behav 134:60\u201365. https:\/\/doi.org\/10.1016\/j.physbeh.2014.02.044","journal-title":"Physiol Behav"},{"issue":"1","key":"9557_CR38","doi-asserted-by":"publisher","first-page":"e15961","DOI":"10.1371\/journal.pone.0015961","volume":"6","author":"J Guo","year":"2011","unstructured":"Guo J, Hall KD (2011) Predicting changes of body weight, body fat, energy expenditure and metabolic fuel selection in C57BL\/6 mice. PLoS ONE 6(1):e15961. https:\/\/doi.org\/10.1371\/journal.pone.0015961","journal-title":"PLoS ONE"},{"issue":"9","key":"9557_CR39","doi-asserted-by":"publisher","first-page":"e1000511","DOI":"10.1371\/journal.pcbi.1000511","volume":"5","author":"J Guo","year":"2009","unstructured":"Guo J, Hall KD (2009) Estimating the continuous-time dynamics of energy and fat metabolism in mice. PLoS Comput Biol 5(9):e1000511. https:\/\/doi.org\/10.1371\/journal.pcbi.1000511","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"9557_CR40","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10928-013-9337-x","volume":"40","author":"P Gennemark","year":"2013","unstructured":"Gennemark P, Jansson-Lofmark R, Hyberg G, Wigstrand M, Kakol-Palm D, Hakansson P, Hovdal D, Brodin P, Fritsch-Fredin M, Antonsson M, Ploj K, Gabrielsson J (2013) A modeling approach for compounds affecting body composition. J Pharmacokinet Pharmacodyn 40(6):651\u2013667. https:\/\/doi.org\/10.1007\/s10928-013-9337-x","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"5","key":"9557_CR41","doi-asserted-by":"publisher","first-page":"e0155674","DOI":"10.1371\/journal.pone.0155674","volume":"11","author":"J Selimkhanov","year":"2016","unstructured":"Selimkhanov J, Thompson WC, Patterson TA, Hadcock JR, Scott DO, Maurer TS, Musante CJ (2016) Evaluation of a mathematical model of rat body weight regulation in application to caloric restriction and drug treatment studies. PLoS ONE 11(5):e0155674. https:\/\/doi.org\/10.1371\/journal.pone.0155674","journal-title":"PLoS ONE"},{"issue":"10","key":"9557_CR42","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s40262-013-0079-0","volume":"52","author":"L Diao","year":"2013","unstructured":"Diao L, Meibohm B (2013) Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides. Clin Pharmacokinet 52(10):855\u2013868. https:\/\/doi.org\/10.1007\/s40262-013-0079-0","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"9557_CR43","first-page":"49","volume":"45","author":"RJ Probst","year":"2006","unstructured":"Probst RJ, Lim JM, Bird DN, Pole GL, Sato AK, Claybaugh JR (2006) Gender differences in the blood volume of conscious Sprague-Dawley rats. J Am Assoc Lab Anim Sci 45(2):49\u201352","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"1","key":"9557_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/21623945.2015.1061723","volume":"5","author":"C Marques","year":"2016","unstructured":"Marques C, Meireles M, Norberto S, Leite J, Freitas J, Pestana D, Faria A, Calhau C (2016) High-fat diet-induced obesity Rat model: a comparison between Wistar and Sprague-Dawley Rat. Adipocyte 5(1):11\u201321. https:\/\/doi.org\/10.1080\/21623945.2015.1061723","journal-title":"Adipocyte"},{"issue":"1","key":"9557_CR45","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/1535370215584890","volume":"241","author":"H Gong","year":"2016","unstructured":"Gong H, Han YW, Sun L, Zhang Y, Zhang EY, Li Y, Zhang TM (2016) The effects of energy intake of four different feeding patterns in rats. Exp Biol Med (Maywood) 241(1):52\u201359. https:\/\/doi.org\/10.1177\/1535370215584890","journal-title":"Exp Biol Med (Maywood)"},{"key":"9557_CR46","doi-asserted-by":"crossref","DOI":"10.1002\/9781118784860","volume-title":"Introduction to population pharmacokinetic\/pharmacodynamic analysis with nonlinear mixed effects models","author":"JS Owen","year":"2014","unstructured":"Owen JS, Fiedler-Kelly J (2014) Introduction to population pharmacokinetic\/pharmacodynamic analysis with nonlinear mixed effects models. Wiley, Hoboken"},{"issue":"5","key":"9557_CR47","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ijo.2013.149","volume":"38","author":"ME Lean","year":"2014","unstructured":"Lean ME, Carraro R, Finer N, Hartvig H, Lindegaard ML, Rossner S, Van Gaal L, Astrup A, Investigators NN (2014) Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults. Int J Obes (Lond) 38(5):689\u2013697. https:\/\/doi.org\/10.1038\/ijo.2013.149","journal-title":"Int J Obes (Lond)"},{"issue":"8","key":"9557_CR48","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1210\/jc.2006-2003","volume":"92","author":"L Aronne","year":"2007","unstructured":"Aronne L, Fujioka K, Aroda V, Chen K, Halseth A, Kesty NC, Burns C, Lush CW, Weyer C (2007) Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study. J Clin Endocrinol Metab 92(8):2977\u20132983. https:\/\/doi.org\/10.1210\/jc.2006-2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5\u20136","key":"9557_CR49","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","volume":"62","author":"SE Kanoski","year":"2012","unstructured":"Kanoski SE, Rupprecht LE, Fortin SM, De Jonghe BC, Hayes MR (2012) The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide. Neuropharmacology 62(5\u20136):1916\u20131927. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.12.022","journal-title":"Neuropharmacology"},{"issue":"8","key":"9557_CR50","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/oby.21563","volume":"24","author":"ST Hjuler","year":"2016","unstructured":"Hjuler ST, Gydesen S, Andreassen KV, Pedersen SL, Hellgren LI, Karsdal MA, Henriksen K (2016) The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesity. Obesity (Silver Spring) 24(8):1712\u20131722. https:\/\/doi.org\/10.1002\/oby.21563","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"9557_CR51","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JOE-14-0405","volume":"223","author":"J Friedman","year":"2014","unstructured":"Friedman J (2014) 20\u00a0years of leptin: leptin at 20: an overview. J Endocrinol 223(1):T1\u2013T8. https:\/\/doi.org\/10.1530\/JOE-14-0405","journal-title":"J Endocrinol"},{"issue":"12","key":"9557_CR52","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1177\/0091270011430504","volume":"52","author":"SH Ingwersen","year":"2012","unstructured":"Ingwersen SH, Khurana M, Madabushi R, Watson E, Jonker DM, Le Thi TD, Jacobsen LV, Tornoe CW (2012) Dosing rationale for liraglutide in type 2 diabetes mellitus: a pharmacometric assessment. J Clin Pharmacol 52(12):1815\u20131823. https:\/\/doi.org\/10.1177\/0091270011430504","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"9557_CR53","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s40262-016-0410-7","volume":"55","author":"RV Overgaard","year":"2016","unstructured":"Overgaard RV, Petri KC, Jacobsen LV, Jensen CB (2016) Liraglutide 3.0\u00a0mg for weight management: a population pharmacokinetic analysis. Clin Pharmacokinet 55(11):1413\u20131422. https:\/\/doi.org\/10.1007\/s40262-016-0410-7","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"9557_CR54","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s40262-014-0229-z","volume":"54","author":"KC Petri","year":"2015","unstructured":"Petri KC, Jacobsen LV, Klein DJ (2015) Comparable liraglutide pharmacokinetics in pediatric and adult populations with type 2 diabetes: a population pharmacokinetic analysis. Clin Pharmacokinet 54(6):663\u2013670. https:\/\/doi.org\/10.1007\/s40262-014-0229-z","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"9557_CR55","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/sj.ijo.0803720","volume":"32","author":"KD Hall","year":"2008","unstructured":"Hall KD (2008) What is the required energy deficit per unit weight loss? Int J Obes (Lond) 32(3):573\u2013576. https:\/\/doi.org\/10.1038\/sj.ijo.0803720","journal-title":"Int J Obes (Lond)"},{"issue":"7","key":"9557_CR56","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/psp4.12199","volume":"6","author":"P Gennemark","year":"2017","unstructured":"Gennemark P, Tragardh M, Linden D, Ploj K, Johansson A, Turnbull A, Carlsson B, Antonsson M (2017) Translational modeling to guide study design and dose choice in obesity exemplified by AZD1979, a melanin-concentrating hormone receptor 1 antagonist. CPT 6(7):458\u2013468. https:\/\/doi.org\/10.1002\/psp4.12199","journal-title":"CPT"},{"issue":"7","key":"9557_CR57","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2105\/AJPH.2014.301931","volume":"104","author":"KD Hall","year":"2014","unstructured":"Hall KD, Hammond RA, Rahmandad H (2014) Dynamic interplay among homeostatic, hedonic, and cognitive feedback circuits regulating body weight. Am J Public Health 104(7):1169\u20131175. https:\/\/doi.org\/10.2105\/AJPH.2014.301931","journal-title":"Am J Public Health"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-017-9557-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-017-9557-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-017-9557-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:56:32Z","timestamp":1693270592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-017-9557-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,23]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["9557"],"URL":"https:\/\/doi.org\/10.1007\/s10928-017-9557-6","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,23]]}}}